These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
197 related items for PubMed ID: 2548214
1. Dopamine D2 receptors in the cerebral cortex: distribution and pharmacological characterization with [3H]raclopride. Lidow MS, Goldman-Rakic PS, Rakic P, Innis RB. Proc Natl Acad Sci U S A; 1989 Aug; 86(16):6412-6. PubMed ID: 2548214 [Abstract] [Full Text] [Related]
2. Distribution of dopaminergic receptors in the primate cerebral cortex: quantitative autoradiographic analysis using [3H]raclopride, [3H]spiperone and [3H]SCH23390. Lidow MS, Goldman-Rakic PS, Gallager DW, Rakic P. Neuroscience; 1991 Aug; 40(3):657-71. PubMed ID: 2062437 [Abstract] [Full Text] [Related]
3. Distribution of dopamine D1 and D2 receptors in rabbit cortical areas, hippocampus, and neostriatum in relation to dopamine contents. Dewar KM, Reader TA. Synapse; 1989 Aug; 4(4):378-86. PubMed ID: 2532424 [Abstract] [Full Text] [Related]
4. Dopamine D2 receptors labeled with [3H]raclopride in rat and rabbit brains. Equilibrium binding, kinetics, distribution and selectivity. Dewar KM, Montreuil B, Grondin L, Reader TA. J Pharmacol Exp Ther; 1989 Aug; 250(2):696-706. PubMed ID: 2527300 [Abstract] [Full Text] [Related]
7. Synthesis and binding properties of the fluorinated substituted benzamide [3H]NCQ 115, a new selective dopamine D2 receptor ligand. Hall H, Högberg T, Halldin C, Bengtsson S, Wedel I. Eur J Pharmacol; 1991 Aug 16; 201(1):1-10. PubMed ID: 1686586 [Abstract] [Full Text] [Related]
8. Effects of monovalent cations on neostriatal dopamine D2 receptors labeled with [3H]raclopride. Reader TA, Boulianne S, Molina-Holgado E, Dewar KM. Biochem Pharmacol; 1990 Oct 15; 40(8):1739-46. PubMed ID: 2146961 [Abstract] [Full Text] [Related]
9. Endogenous dopamine lowers the dopamine D2 receptor density as measured by [3H]raclopride: implications for positron emission tomography of the human brain. Seeman P, Guan HC, Niznik HB. Synapse; 1989 Oct 15; 3(1):96-7. PubMed ID: 2521961 [No Abstract] [Full Text] [Related]
11. Characterization of [3H]quinpirole binding to human dopamine D2A and D3 receptors: effects of ions and guanine nucleotides. Malmberg A, Mohell N. J Pharmacol Exp Ther; 1995 Aug 15; 274(2):790-7. PubMed ID: 7636742 [Abstract] [Full Text] [Related]
13. Link between D1 and D2 dopamine receptors is reduced in schizophrenia and Huntington diseased brain. Seeman P, Niznik HB, Guan HC, Booth G, Ulpian C. Proc Natl Acad Sci U S A; 1989 Dec 15; 86(24):10156-60. PubMed ID: 2574862 [Abstract] [Full Text] [Related]
14. Effects of temperature on the in vitro binding of 3H-raclopride to rat striatal dopamine-D2 receptors. Hall H, Wedel I, Sallemark M. Pharmacol Toxicol; 1988 Aug 15; 63(2):118-21. PubMed ID: 2973009 [Abstract] [Full Text] [Related]
16. Comparisons between the in vitro binding of two substituted benzamides and two butyrophenones to dopamine-D2 receptors in the rat striatum. Hall H, Wedel I. Acta Pharmacol Toxicol (Copenh); 1986 May 15; 58(5):368-73. PubMed ID: 2943136 [Abstract] [Full Text] [Related]
17. In vivo labelling of pituitary dopamine D-2 receptors in the male rat using [3H]-raclopride. Köhler C, Karlsson-Boethius G. J Neural Transm; 1989 May 15; 76(1):13-28. PubMed ID: 2523467 [Abstract] [Full Text] [Related]
18. Distinctions between ligand-binding sites for [3H]dopamine and D2 dopaminergic receptors characterized with [3H]spiroperidol. Hancock AA, Marsh CL. Mol Pharmacol; 1984 Nov 15; 26(3):439-51. PubMed ID: 6238230 [Abstract] [Full Text] [Related]
19. Dopamine D4 receptors elevated in schizophrenia. Seeman P, Guan HC, Van Tol HH. Nature; 1993 Sep 30; 365(6445):441-5. PubMed ID: 8413587 [Abstract] [Full Text] [Related]